Insiders Celyad Oncology SA

Equities

CYAD

BE0974260896

Biotechnology & Medical Research

Real-time Euronext Bruxelles Other stock markets 03:18:19 2026-01-13 am EST			5-day change	1st Jan Change
0.1730 ^EUR	-6.74%		-8.22%	+1.76%

25-09-30	Celyad Oncology to Sell Belgian Research Facility for EUR3 Million	MT
25-09-29	Celyad Oncology announces research facility divestiture	RE

Insiders

24-09-17	Celyad Oncology Names New CEO to Start in October	MT
24-09-16	Celyad Oncology Appoints Matt Kane as Chief Executive Officer, Effective October 1, 2024	CI
23-12-05	Celyad Oncology CEO Resigns	MT
23-12-04	Celyad Oncology CEO Steps Down for Personal Reasons	MT
23-12-04	Celyad Oncology SA Announces Executive Change	CI
23-12-04	Celyad Oncology Sa Announces Executive Change	CI
23-03-24	Celyad Oncology SA Appoints Georges Rawadi as its New Chief Executive Officer	CI
23-03-24	Celyad Oncology Names Georges Rawadi as Chief Executive	MT
23-03-24	Celyad Oncology Appoints New CEO	MT
22-06-24	Celyad Oncology SA Announces Chief Executive Officer Changes	CI
22-06-24	Celyad Oncology Names Michel Lussier Interim Chief Executive, Hilde Windels Chairwoman	MT
22-06-24	Celyad Oncology Names New Chair, Interim CEO	MT
22-06-24	Celyad Oncology SA Announces Board Changes	CI
21-04-19	Celyad Oncology Appoints Dr. Charles Morris as Chief Medical Officer	CI
21-01-11	Celyad Oncology SA Appoints Marina Udier, Ph.D., to Board of Directors	CI
20-05-06	Celyad Announces Board Changes	CI
20-03-11	Celyad Appoints Stephen Rubino as Chief Business Officer	CI
20-03-02	Celyad SA Appoints Stephen Rubino as Chief Business Officer	CI
19-12-03	Celyad SA Announces Directorate Changes	CI
19-11-29	Celyad SA Announces Board Changes	CI
19-03-28	Celyad Appoints Filippo Petti as Chief Executive Officer, Effective April 1, 2019	CI
19-03-08	Celyad Names Anne Moore as Vice President Corporate Strategy	CI
18-09-26	Celyad Appoints Carri Duncan as Vice-President Corporate Development & Communications, Effective on October 1, 2018	CI
18-08-01	Celyad SA Announces Appointment of Dr. Margo Roberts as Board of Director and Its Scientific Committee	CI
16-09-01	Celyad SA Appoints Philippe Dechamps as General Counsel, Company Secretary and Executive Management Team Member	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Insiders Celyad Oncology SA

Equities

CYAD

BE0974260896

Biotechnology & Medical Research

Insiders

Filters